Skip to content

Clinical trials

Phase 2/3 Retinopathy of Prematurity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinopathy of Prematurity Phase: Phase 2/3 Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20101
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asociación para Evitar la Ceguera en México1
Meyer Children's Hospital IRCCS1
NICHD Neonatal Research Network1
National Eye Institute (NEI)1
Shahid Beheshti University of Medical Sciences1
University of California, Los Angeles1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinopathy of Prematurity6
Blindness1
Bronchopulmonary Dysplasia1
Enterocolitis, Necrotizing1
Premature Birth1
Retinal Diseases1
Sepsis1
Systemic Inflammatory Response Syndrome1

Trials

Showing 51 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.